Abstract
The role of the serotonin transporter (5-HTT) in the development of neuropsychiatric disorders has been widely investigated. Two polymorphisms, an insertion/deletion in the promoter region and a 12 repeat allele in a variable nucleotide tandem repeat (VNTR) in intron 2, drive higher expression of the 5-HTT gene. Four studies have shown nominally significant excess transmission of alleles of the 5-HTT gene in autism, while three studies have reported no excess transmission. This present study investigates the role of 5-HTT in the genetically homogenous Irish population. In all, 84 families were genotyped for five polymorphisms (three SNPs, a VNTR and an in/del). The analysis of allele transmissions using the transmission disequilibrium test (TDT) was undertaken and indicated preferential transmission of the short promoter allele (TDT P-value=0.0334). Linkage disequilibrium between markers was calculated and haplotypes were assessed for excess transmission and odds ratios (ORs) to affected children. A number of haplotypes, especially those involving and surrounding SNP10, showed evidence of association. The ORs ranged from 1.2 to 2.4. The most significant haplotype associated with transmission to affected probands was the SNP10–VNTR–SNP18 haplotype (χ2=7.3023, P=0.0069, odds ratio=1.8). This haplotype included the 12 repeat allele of the VNTR, which is associated with increased expression and may play a subtle role in the early development of the brain in affected probands.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Fombonne E . The epidemiology of autism: a review. Psychol Med 1999; 29: 769–786.
Chakrabarti S, Fombonne E . Pervasive developmental disorders in preschool children. JAMA 2001; 285: 3093–3099.
Steffenburg S, Gillberg C, Hellgren L, Andersson L, Gillberg IC, Jakobsson G et al. A twin study of autism in Denmark, Finland, Iceland, Norway and Sweden. J Child Psychol Psychiatry 1989; 30: 405–416.
Bailey A, Le Couteur A, Gottesman I, Bolton P, Simonoff E, Yuzda E et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 1995; 25: 63–77.
Jorde LB, Hassstedt S, Ritvo ER, Mason-Brothers A, Freeman BJ, Pingree C et al. Complex segregation analysis of autism. Am J Hum Genet 1991; 49: 932–938.
Pickles A, Bolton P, Macdonald H, Bailey A, Le Couteur A, Sim CH et al. Latent-class analysis of recurrence risks for complex phenotypes with selection and measurement error: a twin and family history study of autism. Am J Hum Genet 1995; 57: 717–726.
Risch N, Spiker D, Lotspeich L, Nouri N, Hinds D, Hallmayer J et al. A genomic screen of autism: evidence for a multilocus etiology. Am J Hum Genet 1999; 65: 493–507.
Pritchard J . Are rare variants responsible for susceptibility to complex diseases? Am J Hum Genet 2001; 69: 124–137.
Buxbaum JD, Silverman J, Smith CJ, Greenberg DA, Kilifarski M, Reichert J et al. Association between a GABRB3 polymorphism and autism. Mol Psychiatry 2002; 7: 311–316.
Shao Y, Cuccaro M, Hauser ER, Raiford KL, Menold MM, Wolpert CM et al. Fine mapping of autistic disorder to chromosome 15q11–q13 by use of phenotypic subtypes. Am J Hum Genet 2003; 72: 539–548.
Cook Jr EH, Courchesne R, Lord C, Cox NJ, Yan S, Lincoln A et al. Evidence of linkage between the serotonin transporter and autistic disorder. Mol Psychiatry 1997; 2: 247–250.
Klauck SM, Poustka F, Benner A, Lesch KP, Poustka A . Serotonin transporter (5-HTT) gene variants associated with autism? Hum Mol Genet 1997; 6: 2233–2238.
Maestrini E, Lai C, Marlow A, Matthews N, Wallace S, Bailey A et al. Serotonin transporter (5-HTT) and gamma-aminobutyric acid receptor subunit beta3 (GABRB3) gene polymorphisms are not associated with autism in the IMGSA families. Am J Med Genet 1999; 88: 492–496.
Persico AM, Militerni R, Bravaccio C, Schneider C, Melmed R, Conciatori M et al. Lack of association between serotonin transporter gene promoter variants and autistic disorder in two ethnically distinct samples. Am J Med Genet 2000; 96: 123–127.
Betancur C, Corbex M, Spielewoy C, Philippe A, Laplanche JL, Launay JM et al. Serotonin transporter gene polymorphisms and hyperserotonemia in autistic disorder. Mol Psychiatry 2002; 7: 67–71.
International Molecular Genetic Study of Autism Consortium (IMGSAC). A genomewide screen for autism: strong evidence for linkage to chromosomes 2q, 7q, and 16p. Am J Hum Genet 2001; 69: 570–581.
Yonan A, Alarcon M, Cheng R, Magnusson PK, Spence SJ, Palmer AA et al. A genomewide screen of 345 families for autism-susceptibility loci. Am J Hum Genet 2003; 73: 886–897.
Chen H, Clark M, Goldman D . Quantitative autoradiography of 3H-paroxetine binding sites in rat brain. J Pharmacol Toxicol Methods 1992; 27: 209–216.
Hensler JG, Ferry R, Labow DM, Kovachich GB, Frazer A . Quantitative autoradiography of the serotonin transporter to assess the distribution of serotonergic projections from the dorsal raphe nucleus. Synapse 1994; 17: 1–15.
Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996; 274: 1527–1531.
Schain R, Freedman D . Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children. J Pediatr 1961; 58: 315–320.
Abramson RK, Wright H, Carpenter R, Brennan W, Lumpuy O, Cole E et al. Elevated blood serotonin in autistic probands and their first-degree relatives. J Autism Dev Disord 1989; 19: 397–407.
Leboyer M, Philippe A, Bouvard M, Guilloud-Bataille M, Bondoux D, Tabuteau F, Feingold J et al. Whole blood serotonin and plasma beta-endorphin in autistic probands and their first-degree relatives. Biol Psychiatry 1999; 45: 158–163.
McDougle CJ, Naylor S, Cohen DJ, Volkmar FR, Heninger GR, Price LH . A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Arch Gen Psychiatry 1996; 53: 1001–1008.
Lauder J . Ontogeny of the serotonergic system in the rat: serotonin as a developmental signal. Ann NY Acad Sci 1990; 600: 297–313.
Ramamoorthy S, Bauman A, Moore KR, Han H, Yang-Feng T, Chang AS et al. Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci USA 1993; 90: 2542–2546.
MacKenzie A, Quinn J . A serotonin transporter gene intron 2 polymorphic region, correlated with affective disorders, has allele-dependent differential enhancer-like properties in the mouse embryo. Proc Natl Acad Sci USA 1999; 96: 15251–15255.
Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D et al. Allelic variation of human serotonin transporter gene expression. J Neurochem 1996; 66: 2621–2624.
Yirmiya N, Pilowsky T, Nemanov L, Arbelle S, Feinsilver T, Fried I et al. Evidence for an association with the serotonin transporter promoter region polymorphism and autism. Am J Med Genet 2001; 105: 381–386.
Tordjman S, Gutknecht L, Carlier M, Spitz E, Antoine C, Slama F et al. Role of the serotonin transporter gene in the behavioral expression of autism. Mol Psychiatry 2001; 6: 434–439.
Kim SJ, Cox N, Courchesne R, Lord C, Corsello C, Akshoomoff N et al. Transmission disequilibrium mapping at the serotonin transporter gene (SLC6A4) region in autistic disorder. Mol Psychiatry 2002; 7: 278–288.
Lord C, Rutter M, Goode S, Heemsbergen J, Jordan H, Mawhood L et al. Autism diagnostic observation schedule: a standardized observation of communicative and social behavior. J Autism Dev Disord 1989; 19: 185–212.
Lord C, Risi S, Lambrecht L, Cook Jr EH, Leventhal BL, DiLavore PC et al. The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord 2000; 30: 205–223.
Norton N, Williams N, Williams HJ, Spurlock G, Kirov G, Morris DW et al. Universal, robust, highly quantitative SNP allele frequency measurement in DNA pools. Hum Genet 2002; 110: 471–478.
Spielman RS, McGinnis R, Ewens WJ . Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52: 506–516.
Terwilliger JD, Ott J . A haplotype-based ‘haplotype relative risk’ approach to detecting allelic associations. Hum Hered 1992; 42: 337–346.
Purcell S, Sham P . Genetic Power Calculator (2001–2003) http://statgen.iop.kcl.ac.uk/gpc/.
Cook Jr EH, Leventhal BL, Heller W, Metz J, Wainwright M et al. Platelet serotonin studies in hyperserotonemic relatives of children with autistic disorder. Life Sci 1993; 52: 2005–2015.
Tadevosyan-Leyfer O, Dowd M, Mankoski R, Winklosky B, Putnam S, McGrath L et al. A principal components analysis of the autism diagnostic interview—revised. J Am Acad Child Adolesc Psychiatry 2003; 42: 864–872.
Chugani DC, Muzik O, Behen M, Rothermel R, Janisse JJ, Lee J et al. Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Ann Neurol 1999; 45: 287–295.
Herault J, Petit E, Martineau J, Cherpi C, Perrot A, Barthelemy C et al. Serotonin and autism: biochemical and molecular biology features. Psychiatry Res 1996; 65: 33–43.
Lassig JP, Vachirasomtoon K, Hartzell K, Leventhal M, Courchesne E, Courchesne R et al. Physical mapping of the serotonin 5-HT(7) receptor gene (HTR7) to chromosome 10 and pseudogene (HTR7P) to chromosome 12, and testing of linkage disequilibrium between HTR7 and autistic disorder. Am J Med Genet 1999; 88: 472–475.
Herault J, Perrot A, Barthelemy C, Buchler M, Cherpi C, Leboyer M et al. Possible association of c-Harvey-Ras-1 (HRAS-1) marker with autism. Psychiatry Res 1993; 46: 261–267.
Lauritsen MB, Borglum A, Betancur C, Philippe A, Kruse TA, Leboyer M et al. Investigation of two variants in the DOPA decarboxylase gene in patients with autism. Am J Med Genet 2002; 114: 466–470.
Yirmiya N, Pilowsky T, Tidhar S, Nemanov L, Altmark L, Ebstein RP . Family-based and population study of a functional promoter-region monoamine oxidase A polymorphism in autism: possible association with IQ. Am J Med Genet 2002; 114: 284–287.
Philippe A, Guilloud-Bataille M, Martinez M, Gillberg C, Rastam M, Sponheim E et al. Paris Autism Research International Sibpair Study. Analysis of ten candidate genes in autism by association and linkage. Am J Med Genet 2002; 114: 125–128.
Acknowledgements
We thank all the families who participated in this study. This study was supported by funding from the Health Research Board, The Wellcome Trust and the National Alliance for Autism Research.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Conroy, J., Meally, E., Kearney, G. et al. Serotonin transporter gene and autism: a haplotype analysis in an Irish autistic population. Mol Psychiatry 9, 587–593 (2004). https://doi.org/10.1038/sj.mp.4001459
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4001459
Keywords
This article is cited by
-
A systematic review of common genetic variation and biological pathways in autism spectrum disorder
BMC Neuroscience (2021)
-
N-ethylmaleimide-sensitive factor interacts with the serotonin transporter and modulates its trafficking: implications for pathophysiology in autism
Molecular Autism (2014)
-
Association study in siblings and case-controls of serotonin- and oxytocin-related genes with high functioning autism
Journal of Molecular Psychiatry (2014)
-
A review of the serotonin transporter and prenatal cortisol in the development of autism spectrum disorders
Molecular Autism (2013)
-
Association of SLC6A4 variants with obsessive-compulsive disorder in a large multicenter US family study
Molecular Psychiatry (2011)